AKBA
Akebia Ther
NASDAQ: AKBA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.36
-4.23% today
Updated 2026-04-29
Market cap
$364.82M
P/E ratio
—
P/S ratio
1.55x
EPS (TTM)
$-0.02
Dividend yield
—
52W range
$1 – $4
Volume
2.7M
Akebia Ther (AKBA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-7.21M | $-11.33M | $-27.48M | $-52.41M | $57.91M | $-56.16M | $-97.49M | $-257.44M | $-110.39M | $-252.97M | $-73.15M | $-23.38M | $-40.66M | $67.99M |
| Capital expenditures | $0.00 | $19732.00 | $229000.00 | $414000.00 | $2.66M | $1.62M | $1.61M | $6.66M | $317000.00 | $59000.00 | $114000.00 | $0.00 | $33000.00 | $291000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $122000.00 | $1.56M | $6.01M | $4.71M | $5.83M | $8.87M | $19.04M | $11.93M | $24.46M | $22.73M | $17.85M | $9.32M | $7.78M | $11.28M |
| Free cash flow | $-7.21M | $-11.35M | $-27.71M | $-52.82M | $55.24M | $-57.78M | $-99.10M | $-264.10M | $-110.70M | $-253.02M | $-73.27M | $-23.38M | $-40.69M | $67.70M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $11.56M | $17.00M | $137.56M | $-117.18M | $35.66M | $42.70M | $81.33M | $-79.29M | $-58.67M | — | — | — |